These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 28949016)
1. Interleukin 8 mediates bcl-xL-induced enhancement of human melanoma cell dissemination and angiogenesis in a zebrafish xenograft model. Gabellini C; Gómez-Abenza E; Ibáñez-Molero S; Tupone MG; Pérez-Oliva AB; de Oliveira S; Del Bufalo D; Mulero V Int J Cancer; 2018 Feb; 142(3):584-596. PubMed ID: 28949016 [TBL] [Abstract][Full Text] [Related]
2. Modulation of bcl-xL in tumor cells regulates angiogenesis through CXCL8 expression. Giorgini S; Trisciuoglio D; Gabellini C; Desideri M; Castellini L; Colarossi C; Zangemeister-Wittke U; Zupi G; Del Bufalo D Mol Cancer Res; 2007 Aug; 5(8):761-71. PubMed ID: 17699103 [TBL] [Abstract][Full Text] [Related]
3. Involvement of nuclear factor-kappa B in bcl-xL-induced interleukin 8 expression in glioblastoma. Gabellini C; Castellini L; Trisciuoglio D; Kracht M; Zupi G; Del Bufalo D J Neurochem; 2008 Nov; 107(3):871-82. PubMed ID: 18786178 [TBL] [Abstract][Full Text] [Related]
4. Functional activity of CXCL8 receptors, CXCR1 and CXCR2, on human malignant melanoma progression. Gabellini C; Trisciuoglio D; Desideri M; Candiloro A; Ragazzoni Y; Orlandi A; Zupi G; Del Bufalo D Eur J Cancer; 2009 Sep; 45(14):2618-27. PubMed ID: 19683430 [TBL] [Abstract][Full Text] [Related]
5. BCL-X Trisciuoglio D; Tupone MG; Desideri M; Di Martile M; Gabellini C; Buglioni S; Pallocca M; Alessandrini G; D'Aguanno S; Del Bufalo D Cell Death Dis; 2017 Dec; 8(12):3216. PubMed ID: 29238043 [TBL] [Abstract][Full Text] [Related]
6. Exploring association of melanoma-specific Bcl-xL with tumor immune microenvironment. Lucianò AM; Di Martile M; Pérez-Oliva AB; Di Caprio M; Foddai ML; Buglioni S; Mulero V; Del Bufalo D J Exp Clin Cancer Res; 2023 Jul; 42(1):178. PubMed ID: 37488586 [TBL] [Abstract][Full Text] [Related]
7. Distinct expression of CXCL8 and its receptors CXCR1 and CXCR2 and their association with vessel density and aggressiveness in malignant melanoma. Varney ML; Johansson SL; Singh RK Am J Clin Pathol; 2006 Feb; 125(2):209-16. PubMed ID: 16393674 [TBL] [Abstract][Full Text] [Related]
8. Unidirectional crosstalk between Bcl-xL and Bcl-2 enhances the angiogenic phenotype of endothelial cells. Karl E; Zhang Z; Dong Z; Neiva KG; Soengas MS; Koch AE; Polverini PJ; Núñez G; Nör JE Cell Death Differ; 2007 Sep; 14(9):1657-66. PubMed ID: 17572663 [TBL] [Abstract][Full Text] [Related]
9. Bcl-xL: A Focus on Melanoma Pathobiology. Lucianò AM; Pérez-Oliva AB; Mulero V; Del Bufalo D Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33803452 [TBL] [Abstract][Full Text] [Related]
10. Disruption of sphingosine 1-phosphate lyase confers resistance to chemotherapy and promotes oncogenesis through Bcl-2/Bcl-xL upregulation. Colié S; Van Veldhoven PP; Kedjouar B; Bedia C; Albinet V; Sorli SC; Garcia V; Djavaheri-Mergny M; Bauvy C; Codogno P; Levade T; Andrieu-Abadie N Cancer Res; 2009 Dec; 69(24):9346-53. PubMed ID: 19934311 [TBL] [Abstract][Full Text] [Related]
11. BH4 domain of bcl-2 protein is required for its proangiogenic function under hypoxic condition. Gabellini C; De Luca T; Trisciuoglio D; Desideri M; Di Martile M; Passeri D; Candiloro A; Biffoni M; Rizzo MG; Orlandi A; Del Bufalo D Carcinogenesis; 2013 Nov; 34(11):2558-67. PubMed ID: 23836782 [TBL] [Abstract][Full Text] [Related]
12. Zonula occludens-1/NF-κB/CXCL8: a new regulatory axis for tumor angiogenesis. Lesage J; Suarez-Carmona M; Neyrinck-Leglantier D; Grelet S; Blacher S; Hunziker W; Birembaut P; Noël A; Nawrocki-Raby B; Gilles C; Polette M FASEB J; 2017 Apr; 31(4):1678-1688. PubMed ID: 28057697 [TBL] [Abstract][Full Text] [Related]
13. T lymphocyte-dependent and -independent regulation of Cxcl8 expression in zebrafish intestines. Brugman S; Witte M; Scholman RC; Klein MR; Boes M; Nieuwenhuis EE J Immunol; 2014 Jan; 192(1):484-91. PubMed ID: 24277695 [TBL] [Abstract][Full Text] [Related]
14. ShRNA-mediated knock-down of CXCL8 inhibits tumor growth in colorectal liver metastasis. Kumar A; Cherukumilli M; Mahmoudpour SH; Brand K; Bandapalli OR Biochem Biophys Res Commun; 2018 Jun; 500(3):731-737. PubMed ID: 29679563 [TBL] [Abstract][Full Text] [Related]
15. CXCR1/2 antagonism with CXCL8/Interleukin-8 analogue CXCL8(3-72)K11R/G31P restricts lung cancer growth by inhibiting tumor cell proliferation and suppressing angiogenesis. Khan MN; Wang B; Wei J; Zhang Y; Li Q; Luan X; Cheng JW; Gordon JR; Li F; Liu H Oncotarget; 2015 Aug; 6(25):21315-27. PubMed ID: 26087179 [TBL] [Abstract][Full Text] [Related]
16. Bcl-xL and bcl-2 proteins in melanoma progression and UVB-induced apoptosis. Zhang H; Rosdahl I Int J Oncol; 2006 Mar; 28(3):661-6. PubMed ID: 16465371 [TBL] [Abstract][Full Text] [Related]
17. Silencing Daxx increases the anti-tumor activity of a TRAIL/shRNA Bcl-xL-expressing oncolytic adenovirus through enhanced viral replication and cellular arrest. Kang S; Kang D; Bakhtiar Ul Islam SM; Je S; Kim JH; Song JJ Cell Signal; 2015 Jun; 27(6):1214-24. PubMed ID: 25748050 [TBL] [Abstract][Full Text] [Related]
18. Expression of zebrafish cxcl8 (interleukin-8) and its receptors during development and in response to immune stimulation. Oehlers SH; Flores MV; Hall CJ; O'Toole R; Swift S; Crosier KE; Crosier PS Dev Comp Immunol; 2010 Mar; 34(3):352-9. PubMed ID: 19941893 [TBL] [Abstract][Full Text] [Related]
19. Modeling the VEGF-Bcl-2-CXCL8 pathway in intratumoral agiogenesis. Jain HV; Nör JE; Jackson TL Bull Math Biol; 2008 Jan; 70(1):89-117. PubMed ID: 17701379 [TBL] [Abstract][Full Text] [Related]
20. Functional and biological analysis of Bcl-xL expression in human osteosarcoma. Wang ZX; Yang JS; Pan X; Wang JR; Li J; Yin YM; De W Bone; 2010 Aug; 47(2):445-54. PubMed ID: 20580954 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]